AYR Wellness Faces Financial Filing Delays
MIAMI, June 13, 2025 – AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) finds itself in a challenging position as it announces delays in filing its interim financial statements for the first quarter of 2025. This setback affects the company’s anticipated timeline and raises questions about its financial health, especially considering the current operational climate in the cannabis industry.
Reasons Behind the Filing Delay
The primary reason for this delay surrounds AYR's ongoing negotiations with creditors, alongside an important reassessment of the accounting classifications related to certain debts. The company is currently in discussions with a committee of senior lenders, also known as the Ad Hoc Committee. These financial discussions are part of a larger strategic review, addressing how to manage upcoming payment obligations while supporting the company's long-term plans.
The Impact of the Ontario Securities Commission
Adding to the complexity, the Ontario Securities Commission (OSC) has enacted a failure-to-file cease-trade order (FFCTO) against AYR Wellness. This order prohibits trade in AYR’s securities across all Canadian jurisdictions, leading to the suspension of its trading status on the Canadian Securities Exchange (CSE). The company must fulfill all CSE requirements before the FFCTO can be lifted.
Company Response and Future Outlook
Despite these challenges, AYR is diligently working towards completing the necessary interim financial filings. The company has committed to providing an update on the anticipated completion of these filings by June 27, 2025. This proactive approach shows AYR's dedication to transparency and shareholders' interests.
Operational Stability and Commitment to Stakeholders
Importantly, AYR does not foresee the FFCTO affecting its daily operations or its capacity to run its business smoothly. The company continues to focus on delivering high-quality cannabis products to its customers while ensuring the well-being of its employees and maintaining community relations.
About AYR Wellness Inc.
AYR Wellness is more than just a cannabis operator; it is a vertically integrated powerhouse in the U.S. cannabis market, with over 90 licensed dispensaries and a variety of cannabis brands under its umbrella. The company’s mission is to provide top-notch cannabis products while simultaneously acting as a positive force for good within the communities it serves.
Contacting AYR for More Information
For media inquiries, Robert Vanisko, the Senior Vice President of Public Affairs, is available. He can be reached at (786) 885-0397. Additionally, for investor relations, Sean Mansouri, CFA, at Elevate IR, is also accessible at the same phone number.
Frequently Asked Questions
What caused AYR Wellness' delay in financial filings?
The delay stems from ongoing negotiations with creditors and a reassessment of certain debt classifications.
How does the OSC's order affect AYR Wellness?
The OSC's cease-trade order restricts trading of AYR's securities until the interim filings are completed and all requirements are satisfied.
When can shareholders expect updates from the company?
AYR Wellness plans to provide an update on the financial filings by June 27, 2025, or sooner.
Is AYR Wellness able to operate during this period?
Yes, the company does not anticipate the FFCTO to impact its operations negatively.
How can I contact AYR Wellness for more information?
You can reach Robert Vanisko at (786) 885-0397 for media inquiries or Sean Mansouri for investor relations at the same number.
